http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
P-56 Comparison of immunoglobulins in COPD patients between with and without bronchiectasis
( Ju-hee Park ),( Jung-kyu Lee ),( Jungsil Lee ),( Eun Young Heo ),( Hee Soon Chung ),( Deog Kyeom Kim ) 대한결핵 및 호흡기학회 2017 대한결핵 및 호흡기학회 추계학술대회 초록집 Vol.124 No.-
Objective: COPD patients complicated with concurrent bronchiectasis (BE) seemed to present more acute exacerbation and worse clinical course. Meanwhile, several previous presented lower amount of serum immunoglobulin(Ig) in COPD patients. In this report, we compared clinical features COPD patients according to the presence of BE and further, we analyzed the serum Ig level between COPD patients with and without BE in each subtype of Ig. Methods: Retrospective analyses of COPD registry of tertiary referral respiratory center were performed. Detailed history and examination such as pulmonary function test were assessed. Amount of serum Ig were identified with commercially available ELSIA kit and was compared between patients with and without BE. Results: The subjects were composed of 80 COPD patients, 71.61±8.63 years old in average and 76(95%) were males. 22 patients (27.5%) had concurrent BE. FEV1 was 61.10±17.00 %, FVC was 88.70±15.98 % and FEV1/FVC was 48.30±11.29%. Total amounts of IgG, IgE, IgA and IgM were 1433.62±783.52 mg/dl, 0.03±0.06 md/dl, 148.49±59.81 mg/dl and 292.94±210.06 md/dl respectively. The amount of immunoglobulin presented no significant difference according to BE (IgG;p=0.648, IgE;p=0.217 and IgA;p=0.282). COPD patients with BE presented no significant difference with patients without BE in FEV1/FVC (p=0.276) or FEV (p=0.779). Conclusion: COPD patients with BE presented no significant difference not only in the amounts of immunoglobulin, but also in pulmonary function test when compared with patients without BE.
Effect of Prophylactic Use of Silymarin on Anti-tuberculosis Drugs Induced Hepatotoxicity
Heo, Eunyoung,Kim, Deog Kyeom,Oh, So Hee,Lee, Jung-Kyu,Park, Ju-Hee,Chung, Hee Soon The Korean Academy of Tuberculosis and Respiratory 2017 Tuberculosis and Respiratory Diseases Vol.80 No.3
Background: The first line of anti-tuberculosis (TB) drugs are the most effective standard of drugs for TB. However, the use of these drugs is associated with hepatotoxicity. Silymarin has protective effects against hepatotoxicity of anti-TB drugs in animal models. This study aims to investigate the protective effect of silymarin on hepatotoxicity caused by anti-TB drugs. Methods: This is a prospective, randomized, double-blind and placebo-controlled study. Patients were eligible if they were 20 years of age or order and started the first-line anti-tuberculosis drugs. Eligible patients were randomized for receiving silymarin or a placebo for the first 4 weeks. The primary outcome was the proportion of patients who showed elevated serum liver enzymes more than 3 times the upper normal limit (UNL) or total bilirubin (TBil) > $2{\times}UNL$ within the first 8 weeks of anti-TB treatment. Results: We enrolled a total of 121 patients who silymarin or a placebo to start their anti-TB treatment, for the first 8 weeks. The proportions of elevated serum liver enzymes more than 3 times of UNL at week 2, week 4, and week 8 did not show any significant difference between the silymarin and placebo groups, at 0% versus 3.6% (p>0.999); 4.4% versus 3.6% (p>0.999); and 8.7% versus 10.8% (p=0.630), respectively. However, patients with TBil >$2{\times}UNL$ at week 8 were significantly low in the silymarin group (0% versus 8.7%, p=0.043). Conclusion: Our findings did not show silymarin had any significant preventive effect on the hepatotoxicity of anti-TB drugs.
안주희(Ju Hee Ahn),허영선(Young Sun Heo),강응택(Eung Taek Kang),유석희(Suk Hee Yu) 대한내과학회 2000 대한내과학회지 Vol.59 No.5
Malaria infection is not uncommon in Korea these days, but there was no report of malaria infection in the patients who had been transplanted his or her kidney. With the immunosuppression, the atypical findings are frequent and make prompt diagnosis difficult. We report a case of malaria which showed atypical clinical course but treated successfully with conventional anti-malarial drug therapy. A 37 year old male patient were transplanted his kidney in Sep. 1997. He was admitted because of fever, which lasted 40 - 50 min every afternoon for 27 days. Numerous trophozoites were found on his peripheral blood smear, which was diagnosed as vivax malaria. Chloroquine and primaquine were given, and fever subsided next day. The patients has been stayed afebrile thereafter. We reported a case of malaria in the renal transplanted patient with the review of literatures. (Korean J Med 59:540-543, 2000)